Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-21-026595

Chief Commercial Officer sold 3,899 shares at $35.06 ($136,699)

  • Chief Commercial Officer acquired 3,899 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-25 Exercise or conversion : show line 1 in the form +3,899 $0.28 $1,092 49,975 D
2021-06-25 Sale : show line 2 in the form −3,899 $35.06 $136,699 46,076 D
Open-market sales · 3,899 sh · avg $35.06 · $136,699

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-06-25 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −3,899 $0.28 2023-05-29 3,899 28,278 D
Loading xslF345X03/doc4.xml…